No Data
No Data
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)
Express News | HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target
Agenus Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/07/2024 229.49% HC Wainwright & Co. → $40 Reiterates Buy → Buy 03/18/2024 -58.81% B. Riley Securities $
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals (LGND) and Agenus (AGEN) said Tuesday they have signed a royalty financing agreement to support the clinical development of Agenus' botensilimab and balstilimab, including a con
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments